FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

38372111000001104: Nubeqa 300mg tablets (Bayer Plc) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 10-Jun 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1383021000001117 Nubeqa 300mg tablets (Bayer Plc) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1383041000001110 Nubeqa 300mg tablets (Bayer Plc) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nubeqa 300mg tablets (Bayer Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Nubeqa 300mg tablets (Bayer Plc) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Nubeqa 300mg tablets (Bayer Plc) Has excipient Lactose false Inferred relationship Existential restriction modifier
Nubeqa 300mg tablets (Bayer Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Nubeqa 300mg tablets (Bayer Plc) Is a Darolutamide 300mg tablets true Inferred relationship Existential restriction modifier
Nubeqa 300mg tablets (Bayer Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Nubeqa 300mg tablets (Bayer Plc) Is a Nubeqa true Inferred relationship Existential restriction modifier
Nubeqa 300mg tablets (Bayer Plc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Nubeqa 300mg tablets (Bayer Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Nubeqa 300mg tablets (Bayer Plc) Has specific active ingredient Darolutamide false Inferred relationship Existential restriction modifier
Nubeqa 300mg tablets (Bayer Plc) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Nubeqa 300mg tablets (Bayer Plc) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Nubeqa 300mg tablets (Bayer Plc) Has specific active ingredient Darolutamide true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Nubeqa 300mg tablets (Bayer Plc) 112 tablet 7 x 16 tablets Has AMP True Nubeqa 300mg tablets (Bayer Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start